R. Wallace

Publications385
h-index90
Citations28,661
Highly Influential Citations1,357
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • B. Brown-Elliott
  • 143 Publications • 12,771 Citations
  • D. Griffith
  • 261 Publications • 11,094 Citations
  • B. Brown
  • 78 Publications • 6,770 Citations
  • E. Böttger
  • 543 Publications • 20,469 Citations
  • Publications
  • Influence
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.
Diagnostic Criteria of Nontuberculous Mycobacterial Lung Disease Key Laboratory Features of NTM Health Careand Hygiene-associated Disease Prevention Prophylaxis and Treatment of NTM Disease… Expand
  • 4,130
  • 519
  • PDF
Clinical and Laboratory Features of the Nocardia spp. Based on Current Molecular Taxonomy
SUMMARY The recent explosion of newly described species of Nocardia results from the impact in the last decade of newer molecular technology, including PCR restriction enzyme analysis and 16S rRNA… Expand
  • 742
  • 80
  • PDF
Clinical and Taxonomic Status of Pathogenic Nonpigmented or Late-Pigmenting Rapidly Growing Mycobacteria
SUMMARY The history, taxonomy, geographic distribution, clinical disease, and therapy of the pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria (RGM) are reviewed.… Expand
  • 723
  • 53
  • PDF
Diagnosis and treatment of disease caused by nontuberculous mycobacteria.
Diagnostic Criteria of Nontuberculous Mycobacterial Lung Disease For patients with a cavitary infiltrate: Two or more sputums or bronchial washings that are acid-fast bacilli smear positive and/or… Expand
  • 1,029
  • 23
  • PDF
Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients.
The role of rapidly growing mycobacteria (RGM) as pulmonary pathogens has been unclear. We identified 154 cases of lung disease caused by RGM using the microbiologic and radiographic criteria of the… Expand
  • 445
  • 23
A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae
ABSTRACT Mycobacterium abscessus infections tend to respond poorly to macrolide-based chemotherapy, even though the organisms appear to be susceptible to clarithromycin. Circumstantial evidence… Expand
  • 388
  • 21
  • PDF
Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.
Nontuberculous mycobacteria (NTM) are potential respiratory pathogens in cystic fibrosis (CF). To assess the species-specific prevalence and risk factors for acquisition, we conducted a prospective,… Expand
  • 499
  • 20
Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria
SUMMARY Within the past 10 years, treatment and diagnostic guidelines for nontuberculous mycobacteria have been recommended by the American Thoracic Society (ATS) and the Infectious Diseases Society… Expand
  • 330
  • 18
Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria.
Nosocomial outbreaks and pseudo-outbreaks caused by the nontuberculous mycobacteria (NTM) have been recognized for more than 20 years and continue to be a problem. Most of these outbreaks have… Expand
  • 389
  • 17
Spectrum of disease due to rapidly growing mycobacteria.
One hundred twenty-five cases of disease due to rapidly growing mycobacteria were observed over a four-year period. Cutaneous infections accounted for 74 cases (59%). Of these, 40 followed surgical… Expand
  • 536
  • 16
...
1
2
3
4
5
...